St. Jude Medical on Monday announced the European approval of its Portico transcatheter aortic heart valve, which allows doctors to treat severe aortic stenosis for inoperable or high risk patients without open heart surgery.
With the announcement, St. Jude joins a growing roster of companies that are making a less-invasive way to treat what is a very dangerous disease. Aortic stenosis is a narrowing of the aortic heart valve that decreases blood flow from the heart. Before the advent of transcatheter aortic valve replacement (TAVR), the only way to replace a diseased aortic valve was through open heart surgery. Problem was, some patients are deemed too sick for open heart surgery to risk it.
But, without valve replacement, as many as half of those with severe aortic stenosis die within a year.
Transcatheter valve replacement allows doctors to insert a new valve into the heart by snaking a catheter up into the patient through an artery in the leg. Patients can be home from the hospital within a couple of days, instead of weeks after open heart surgery.
Currently, only Edwards Lifesciences, based in California, has the only transcatheter valve approved for sale in the United States. Medtronic is currently marketing its own TAVR product in Europe and expects to gain U.S. approval in 2014. Boson Scientific also is developing a similar product, which is expected to win European approval in late 2013.
St. Jude’s Portico valve can be resheathed and repositioned – or withdrawn – before it is released from its delivery system, allowing physicians more flexibility in placing the valve and preventing possible leakage around the valve, St. Jude said.
More from Star Tribune
More from Patent Pending
Published reports in medical journals are more likely to not mention adverse event that reports to government. according to OHSU study.
The Natick, Mass. company's operations at its Maple Grove facilities honored for business improvement.
Consumers Union pushing for med tech companies to provide warranties for hips and knees.
Runners who have benefited from medical technology are encouraged to apply.
The University of Iowa is one of four sites to host small clinical trial of new technology to treat tinnitus.
Recommended For You
Congress voted overwhelmingly Wednesday to allow families of Sept. 11 victims to sue Saudi Arabia for its alleged backing of the attackers, handing Barack Obama the first veto override of his presidency.
Comparing environmental successes to on-the-field failures, Twins president Dave St. Peter used an expletive when he cited 'the thing we screwed up' to a group at the University of Minnesota.
The GOP nominee wasn't up to the task in first presidential debate.
Attention, Wells Fargo customers: It's time to sit down and make sure no funny business went on with your accounts. But don't wait around for a phone call. You must be proactive.
The Ryder Cup is the one time on the golf calendar when the genteel civility usually associated with the sport gets packed away for a few days.